基于疫苗犹豫与偏好异质性解析中国家长HPV疫苗接种决策:离散选择实验
在中国大陆招募1062名9-14岁未接种HPV疫苗女孩的家长完成离散选择实验,评估保护效力、保护时长、轻微副作用可能性、生产国和价格五个疫苗属性。混合logit模型显示所有属性均显著影响偏好,高犹豫家长更看重效力和时长且更偏好进口疫苗;基线接种意愿35.9%,最优情景可升至99.2%。
要点
- 保护效力和保护时长是高、低犹豫家长均最重视的疫苗属性。
- 高犹豫家长对效力和时长权重更大,且更偏好进口疫苗。
- 优化疫苗属性可将预测接种率从基线35.9%提升至最优情景99.2%。
核心结论
- 家长对HPV疫苗属性的偏好因疫苗犹豫程度而异。
- 优化保护效力和保护时长等属性可能大幅提升接种接受度。
- 需配合有效公共沟通并增强对国产疫苗的信任。
研究设计与样本
- 在中国大陆招募1062名9-14岁未接种HPV疫苗女孩的家长。
- 采用离散选择实验评估五类疫苗属性偏好。
- 使用HPV疫苗犹豫量表测量犹豫程度,并以混合logit模型分析偏好异质性。
主要发现
- 所有疫苗属性均显著影响家长偏好。
- 保护效力和保护时长对高犹豫与低犹豫家长均为最重要属性。
- 高犹豫家长对效力和时长赋予更大权重,且更偏好进口疫苗。
- 基线情景预测接种率为35.9%,最优情景预测升至99.2%。
临床怎么用
- 针对高犹豫家长应重点沟通疫苗保护效力和保护时长。
- 提升国产疫苗信任度以配合国家免疫规划实施。
- 依据家长犹豫程度设计差异化沟通策略以提高接种覆盖。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human papillomavirus (HPV) vaccination is an effective strategy for preventing cervical cancer. However, persistent vaccine hesitancy remains a major barrier to widespread HPV vaccination. In line with the WHO's global strategy to eliminate cervical cancer, China announced in September 2025 that HPV vaccination would be included in the National Immunisation Programme. Understanding how parental preferences for different HPV vaccine attributes differ according to level of vaccine hesitancy is therefore essential to inform effective communication strategies and support the successful implementation of the new national programme. METHODS: We recruited parents of girls aged 9-14 years in mainland China who had not received the HPV vaccine. A total of 1062 participants completed a discrete choice experiment to examine parental preferences for vaccinating their children. Five vaccine attributes were evaluated: protection efficacy, duration of protection, possibility of minor side effects, vaccine's country of manufacture, and price. The HPV Vaccine Hesitancy Scale was used to measure participants' degree of vaccine hesitancy. A mixed logit model was employed to explore preference heterogeneity according to level of vaccine hesitancy among participants. RESULTS: All vaccine attributes significantly influenced parental preferences. Protective efficacy and duration of protection were the most important attributes for both high-hesitancy and low-hesitancy parents. Preferences differed by hesitancy level: parents with higher hesitancy assigned greater weight to efficacy and duration, and showed greater preference for imported vaccines. Under the baseline scenario, the predicted uptake was 35.9%, whereas the optimal scenario, characterised by high efficacy, forever protection, low cost, minimal side effects, and domestic production, was projected to increase uptake to 99.2%. CONCLUSION: Parental preference of HPV vaccine attributes varied across vaccine hesitancy groups. Optimisation of vaccine attributes, particularly protection efficacy and duration of protection, may substantially enhance acceptance, supported by effective public communication and strengthened trust in domestically produced vaccines. These findings provide evidence to inform targeted strategies for increasing HPV vaccination coverage in China.
引用
- Lu Y, Tang C, Xu S, et al. Understanding parental HPV vaccination decision in China through the lens of vaccine hesitancy and preference heterogeneity: a discrete choice experiment. Vaccine. 2026. PMID: 41666789. doi:10.1016/j.vaccine.2026.128307
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。